Abstract
Ushbu maqolada Bachadon miomasi (bachadon fibromiomasi)ni davolashning konservativ va jarrohlik usullarining samaradorligi o‘zaro taqqoslab tahlil qilinadi. Tadqiqotning dolzarbligi reproduktiv yoshdagi ayollar orasida ushbu kasallikning yuqori uchrash darajasi, simptomlarning hayot sifatiga sezilarli ta’siri hamda optimal davolash strategiyasini tanlashdagi murakkablik bilan izohlanadi. Maqolada konservativ davolash usullari, jumladan gormonal terapiya (gonadotropin-releasing gormon agonistlari, progestinlar), simptomatik yondashuvlar hamda minimal invaziv muolajalar (masalan, uterin arteriya embolizatsiyasi)ning klinik samaradorligi ko‘rib chiqiladi.
Shuningdek, jarrohlik davolash usullari – miomektomiya va histerektomiya – ning ko‘rsatmalari, afzalliklari, asoratlari hamda uzoq muddatli natijalari tahlil qilinadi. Tadqiqot natijalari shuni ko‘rsatadiki, konservativ yondashuv ayrim hollarda simptomlarni kamaytirishda samarali bo‘lsa-da, kasallikning qaytalanish ehtimoli yuqoriroq bo‘lishi mumkin. Jarrohlik usullari esa radikal natija berishi bilan birga, invazivligi va reproduktiv funksiyaga ta’siri sababli ehtiyotkorlik bilan tanlanishi lozim.
References
1. Berek J.S. Berek & Novak’s Gynecology. Lippincott Williams & Wilkins, 16th edition, 2020.
2. Cunningham F.G. et al. Williams Obstetrics. McGraw-Hill Education, 26th edition, 2022.
3. Stewart E.A. Clinical practice. Uterine fibroids. New England Journal of Medicine, 2015.
4. FIGO Guidelines on the Management of Uterine Leiomyomas, 2021.
5. ACOG Practice Bulletin No. 228: Management of Symptomatic Uterine Leiomyomas, 2021.
6. Bulun S.E. Uterine Fibroids. New England Journal of Medicine, 2013.
7. Speroff L., Fritz M.A. Clinical Gynecologic Endocrinology and Infertility. 9th edition, 2019.
8. Клинические рекомендации по диагностике и лечению миомы матки. Министерство здравоохранения РФ, 2020.
9. Novak E. Gynecologic and Obstetric Pathology. 2018.
10. UpToDate. Uterine fibroids: clinical manifestations and diagnosis (latest update).